Parsons James T. bought ONCY
March 11, 2026 · Form 4 insider transaction
Parsons James T. bought 10,000 shares of Oncolytics Biotech Inc. at $1.03 per share, a transaction worth $10.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$1.03
Total value
$10.3K
InsiderParsons James T.
RoleDirector
SecurityCommon Shares
Transaction codeP: Open-market purchase
Transaction dateMarch 11, 2026
Filing dateMarch 13, 2026
Shares owned after41,849
OwnershipDirect
10b5-1 planNo
AmendedNo